In Vitro Assessment of Lactobacillus crispatus UBLCp01, Lactobacillus gasseri UBLG36, and Lactobacillus johnsonii UBLJ01 as a Potential Vaginal Probiotic Candidate

Probiotics Antimicrob Proteins. 2023 Apr;15(2):275-286. doi: 10.1007/s12602-021-09838-9. Epub 2021 Aug 20.

Abstract

In this study, Lactobacillus crispatus UBLCp01, Lactobacillus gasseri UBLG36, and Lactobacillus johnsonii UBLJ01 isolated from the vagina of healthy reproductive age Indian women were screened for beneficial probiotic properties. These strains showed the ability to survive acidic and simulated vaginal fluid conditions and could adhere to mucin. Lact. gasseri UBLG36, and Lact. johnsonii UBLJ01 produced D- and L-lactic acid, whereas Lact. crispatus UBLCp01 produced hydrogen peroxide and D- and L-lactic acid. All strains inhibited the growth of pathogens (Escherichia coli, Gardnerella vaginalis, Proteus mirabilis, and Candida albicans) and were capable of co-aggregating with them with varying degrees. Strains secreted exopolysaccharides and formed biofilms under in vitro conditions. Safety assessment showed that these strains had a usual antibiotic susceptibility profile, did not produce hemolysins, gelatinases, and mucin degrading enzymes. Based on strain characteristics and beneficial properties, we believe that these strains are promising candidates for human trials to confirm their ability to prevent/treat vaginal dysbiosis and maintain a healthy vaginal eco-system.

Keywords: Dysbiosis; Lact. crispatus UBLCp01; Lact. gasseri UBLG36; Lact. johnsonii UBLJ01; Simulated vaginal fluid; Vaginal probiotics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Escherichia coli
  • Female
  • Humans
  • Lactic Acid
  • Lactobacillus
  • Lactobacillus crispatus*
  • Lactobacillus gasseri*
  • Lactobacillus johnsonii*
  • Probiotics* / pharmacology
  • Vagina

Substances

  • Lactic Acid